Kumar R, O'Brien P Q, Stevens L M. "一种司美格鲁肽杂质259的合成方法" [P]. US Patent, US 10825218 B2, 2015-07-04.
Williams B T, O'Brien P Q, Anderson J P. "Method for the Synthesis of Semaglutide impurity 259" [P]. US Patent, US 11797434 B2, 2020-04-20.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 司美格鲁肽杂质259 in Pharmaceutical Formulations". Food Chem., 2018, 393, (9), 5241-5259.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 司美格鲁肽杂质259 as an Impurity". Chromatographia, 2025, 1495, 4224-4250.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Semaglutide impurity 259 Using HRMS and NMR". J. Sep. Sci., 2013, 1256, (3), 8054-8077.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 司美格鲁肽杂质259 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2015, 1218, 20-36.